Conventional endoscopic mucosal resection versus modified endoscopic mucosal resection for duodenal neuroendocrine tumor
Authors:
- 30 January 2023
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (5) , 3884-3892
Abstract
Background and aims As the incidence of duodenal neuroendocrine tumors (DNET) is steadily increasing, the role of endoscopic treatment for appropriate lesions is becoming more significant. We aimed to compare the outcomes according to lesion size and endoscopic mucosal resection (EMR) techniques for DNET treatment. Patients and methods Patients who underwent endoscopic treatment for DNET between June 2000 and December 2019 were included. The clinicopathologic features and treatment outcomes were investigated by reviewing medical records. Results Overall, 104 cases underwent endoscopic resection for nonampullary DNET, including conventional EMR (n = 57), cap-assisted EMR (EMR-C, n = 19), and precut EMR (EMR-P, n = 28). The en bloc resection rates (100% vs. 94.7% vs. 96.4%) and histologic complete resection rates (45.6% vs. 52.6% vs. 57.1%) were not significantly different between the EMR, EMR-C, and EMR-P groups. The histologic complete resection rates were significantly higher in lesions < 10 mm than in lesions ≥ 10 mm (69.8% vs. 38.9%, P = 0.013). In lesions < 10 mm, perforation occurred more frequently in the modified EMR group than in the conventional EMR group (13.2% vs. 0.0%, P = 0.007). During the median follow-up period of 88.0 months, the recurrence-free survival (92.2% vs. 94.4% vs. 92.1%) and overall survival (98.0% vs. 88.1% vs. 100.0%) rates did not show significant differences between the EMR, EMR-C, and EMR-P groups. Conclusion Conventional EMR and modified EMR are feasible and effective for the treatment of nonampullary DNET sized < 10 mm and limited to mucosal and submucosal layer. Additionally, endoscopists should be aware of the high risk of perforation in modified EMR.Keywords
This publication has 22 references indexed in Scilit:
- A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates PrognosisJournal of Gastrointestinal Surgery, 2016
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine NeoplasmsNeuroendocrinology, 2016
- Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine TumorsSurgical Laparoscopy, Endoscopy & Percutaneous Techniques, 2015
- Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?Surgery, 2015
- The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its IntroductionEndocrine Pathology, 2014
- Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine TumorsJournal of Gastrointestinal Surgery, 2014
- Endoscopic resection for duodenal carcinoid tumors: A multicenter, retrospective studyJournal of Gastroenterology and Hepatology, 2013
- Endoscopic Treatment of Duodenal Neuroendocrine TumorsClinical Endoscopy, 2013
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Neuroendocrine tumours of the duodenumLangenbeck's Archives of Surgery, 2001